In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Tenet Healthcare Corp (NYSE: THC) closed at $198.32 up 1.87% from its previous closing price of $194.68. In other words, the price has increased by $1.87 from its previous closing price. On the day, 1.11 million shares were traded. THC stock price reached its highest trading level at $202.26 during the session, while it also had its lowest trading level at $193.0.
Ratios:
For a deeper understanding of Tenet Healthcare Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.60. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.29 whereas as Long-Term Debt/Eq ratio is at 3.26.
Wells Fargo Upgraded its Equal Weight to Overweight on May 29, 2025, while the target price for the stock was maintained at $195.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 06 ’25 when Ramsey R. Scott sold 13,322 shares for $205.11 per share. The transaction valued at 2,732,439 led to the insider holds 0 shares of the business.
Romo Tammy sold 645 shares of THC for $132,354 on Nov 05 ’25. The Director now owns 34,866 shares after completing the transaction at $205.20 per share. On Nov 06 ’25, another insider, Ramsey R. Scott, who serves as the Officer of the company, bought 13,322 shares for $205.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 17429354496 and an Enterprise Value of 32327352320. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.60, and their Forward P/E ratio for the next fiscal year is 12.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 4.34. Its current Enterprise Value per Revenue stands at 1.551 whereas that against EBITDA is 7.23.
Stock Price History:
The Beta on a monthly basis for THC is 1.46, which has changed by 0.19486892 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $217.43, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is -0.21%, while the 200-Day Moving Average is calculated to be 21.78%.
Shares Statistics:
For the past three months, THC has traded an average of 1.08M shares per day and 1128330 over the past ten days. A total of 87.87M shares are outstanding, with a floating share count of 86.84M. Insiders hold about 1.19% of the company’s shares, while institutions hold 98.41% stake in the company. Shares short for THC as of 1761868800 were 2618909 with a Short Ratio of 2.36, compared to 1759190400 on 2466616. Therefore, it implies a Short% of Shares Outstanding of 2618909 and a Short% of Float of 4.01.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
The stock of Tenet Healthcare Corp (THC) is currently drawing attention from 17.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $4.44, with high estimates of $4.86 and low estimates of $3.82.
Analysts are recommending an EPS of between $16.33 and $15.77 for the fiscal current year, implying an average EPS of $16.08. EPS for the following year is $16.47, with 20.0 analysts recommending between $17.8 and $14.2.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $5.46B this quarter.It ranges from a high estimate of $5.52B to a low estimate of $5.36B. As of. The current estimate, Tenet Healthcare Corp’s year-ago sales were $5.07BFor the next quarter, 17 analysts are estimating revenue of $5.45B. There is a high estimate of $5.51B for the next quarter, whereas the lowest estimate is $5.38B.
A total of 19 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.5B, while the lowest revenue estimate was $21.06B, resulting in an average revenue estimate of $21.25B. In the same quarter a year ago, actual revenue was $20.66BBased on 19 analysts’ estimates, the company’s revenue will be $22.17B in the next fiscal year. The high estimate is $22.55B and the low estimate is $21.8B.
